Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer
出版年份 2021 全文链接
标题
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer
作者
关键词
-
出版物
BIOSCIENCE REPORTS
Volume 41, Issue 1, Pages -
出版商
Portland Press Ltd.
发表日期
2021-01-14
DOI
10.1042/bsr20203115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer
- (2020) Zhi‐Hua Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining
- (2019) Yan Lin et al. Aging-US
- Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial
- (2019) Eric Assenat et al. BRITISH JOURNAL OF CANCER
- Mechanisms of hepatocellular carcinoma progression
- (2019) Olorunseun O Ogunwobi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
- (2019) Ziyu Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Random forest-based modelling to detect biomarkers for prostate cancer progression
- (2019) Reka Toth et al. Clinical Epigenetics
- Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
- (2019) Marc Hilmi et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy for hepatocellular carcinoma
- (2019) Yin Zongyi et al. CANCER LETTERS
- MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2
- (2019) Dan Yu et al. CELLULAR ONCOLOGY
- ZIC1 acts a tumor suppressor in breast cancer by targeting survivin
- (2018) Wei Han et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Immune checkpoint therapy in liver cancer
- (2018) Feng Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer
- (2018) Ying-Fang Wang et al. CANCER BIOLOGY & THERAPY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- MiR-1284 inhibits the growth and invasion of breast cancer cells by targeting ZIC2
- (2018) Pengcheng Zhang et al. ONCOLOGY RESEARCH
- Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression
- (2018) Qi Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2
- (2018) Xiaohe Chen et al. Molecular Medicine Reports
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Sorafenib: A Review in Hepatocellular Carcinoma
- (2017) Gillian M. Keating Targeted Oncology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Roles of ZIC family genes in human gastric cancer
- (2016) GANG MA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hepatocellular Carcinoma
- (2015) Richard L. Hesketh et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study
- (2015) Ying Liu et al. International Journal of Clinical Oncology
- ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells
- (2015) Pingping Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- ZIC1Is a Putative Tumor Suppressor in Thyroid Cancer by Modulating Major Signaling Pathways and Transcription Factor FOXO3a
- (2014) Wei Qiang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pragmatic issues in biomarker evaluation for targeted therapies in cancer
- (2014) Armand de Gramont et al. Nature Reviews Clinical Oncology
- The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
- (2011) H. Wong et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started